Alcami has announced its first to market Protect Your Brand™ offering, which it said will support companies looking to implement a backup supply option.
As the company tries to move out from under Shkreli's cloud, KaloBios has announced a new product pricing model that promises transparency, affordably, and reasonable return.
With more than 90% of revenue coming from pharma and biotech companies outside the top 25, CRO SynteractHCR is seeing more growth stemming from an influx of funding to smaller biotech companies, CEO Wendel Barr told us on the third day of the 51st annual...
Growing demand has prompted tableting specialist Meldex
International, formerly BioProgress, to launch a new sales and
distribution hub in Germany, with the UK firm also announcing a new
manufacturing contract for its XGel film.
Some of the world's largest pharma firms have set out what
therapeutic areas and specific mechanisms are becoming more
important to them, and which will be left by the wayside.
Indian biopharmaceutical company Wockhardt Limited has continued
its push into Europe with the all-cash acquisition of France's
Negma Laboratories (Negma-Lerads) for $265m (€195.4m).
A new market-oriented approach to product development, more
favourable licensing arrangements, strategic acquisitions and a
fresh crop of proprietary drug-delivery technologies helped UK
company BioProgress to deliver an adjusted...
Canadian contract manufacturer Patheon has announced a $150m
(€114m) investment by a private equity firm - a move the company
sees as the best viable option to end its financial misery.
Caliper Technologies has been given the go-ahead by the US federal
Trade Commission for its $71 million cash and stock acquisition of
Zymark, a specialist in laboratory automation and robotics
equipment.
